156 related articles for article (PubMed ID: 10755224)
1. New 1,4-anthracene-9,10-dione derivatives as potential anticancer agents.
Zagotto G; Supino R; Favini E; Moro S; Palumbo M
Farmaco; 2000 Jan; 55(1):1-5. PubMed ID: 10755224
[TBL] [Abstract][Full Text] [Related]
2. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxic effect of 1,3-dihydroxy-9,10-anthraquinone derivatives.
Wei BL; Wu SH; Chung MI; Won SJ; Lin CN
Eur J Med Chem; 2000 Dec; 35(12):1089-98. PubMed ID: 11248407
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, Molecular Docking, and Biological Evaluation of New Emodin Anthraquinone Derivatives as Potential Antitumor Substances.
Li Y; Guo F; Chen T; Zhang L; Wang Z; Su Q; Feng L
Chem Biodivers; 2020 Sep; 17(9):e2000328. PubMed ID: 32627416
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
7. Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.
Liang YK; Yue ZZ; Li JX; Tan C; Miao ZH; Tan WF; Yang CH
Eur J Med Chem; 2014 Sep; 84():505-15. PubMed ID: 25050882
[TBL] [Abstract][Full Text] [Related]
8. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone.
Huang HS; Chiou JF; Fong Y; Hou CC; Lu YC; Wang JY; Shih JW; Pan YR; Lin JJ
J Med Chem; 2003 Jul; 46(15):3300-7. PubMed ID: 12852760
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxic evaluation of two novel anthraquinone derivatives.
Sadeghi-Aliabadi H; Tabarzadi M; Zarghi A
Farmaco; 2004 Aug; 59(8):645-9. PubMed ID: 15262534
[TBL] [Abstract][Full Text] [Related]
10. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
[TBL] [Abstract][Full Text] [Related]
11. Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents.
Lee YR; Chen TC; Lee CC; Chen CL; Ahmed Ali AA; Tikhomirov A; Guh JH; Yu DS; Huang HS
Eur J Med Chem; 2015 Sep; 102():661-76. PubMed ID: 26344783
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer structure activity relationship investigation of cationic anthraquinone analogs.
Shrestha JP; Fosso MY; Bearss J; Chang CW
Eur J Med Chem; 2014 Apr; 77():96-102. PubMed ID: 24631728
[TBL] [Abstract][Full Text] [Related]
13. Design and Syntheses of Novel Fluoroporphyrin-Anthraquinone Complexes as Antitumor Agents.
Yang GL; Zhao SF; Chen NY; Li S
Chem Pharm Bull (Tokyo); 2016; 64(9):1310-4. PubMed ID: 27581635
[TBL] [Abstract][Full Text] [Related]
14. Antitumor agents--CLXVII. Synthesis and structure-activity correlations of the cytotoxic anthraquinone 1,4-bis-(2,3-epoxypropylamino)-9,10-anthracenedione, and of related compounds.
Johnson MG; Kiyokawa H; Tani S; Koyama J; Morris-Natschke SL; Mauger A; Bowers-Daines MM; Lange BC; Lee KH
Bioorg Med Chem; 1997 Aug; 5(8):1469-79. PubMed ID: 9313853
[TBL] [Abstract][Full Text] [Related]
15. Antitumor potential of aza-bioisosterism in anthracenedione-based drugs.
Sissi C; Palumbo M
Curr Top Med Chem; 2004; 4(2):219-30. PubMed ID: 14754455
[TBL] [Abstract][Full Text] [Related]
16. One Pot and Metal-Free Approach to 3-(2-Hydroxybenzoyl)-1-aza-anthraquinones.
Yuan J; He Q; Song S; Zhang X; Miao Z; Yang C
Molecules; 2019 Aug; 24(16):. PubMed ID: 31434258
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents.
Chen TC; Yu DS; Huang KF; Fu YC; Lee CC; Chen CL; Huang FC; Hsieh HH; Lin JJ; Huang HS
Eur J Med Chem; 2013 Nov; 69():278-93. PubMed ID: 24051300
[TBL] [Abstract][Full Text] [Related]
18. Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype.
Volodina YL; Tikhomirov AS; Dezhenkova LG; Ramonova AA; Kononova AV; Andreeva DV; Kaluzhny DN; Schols D; Moisenovich MM; Shchekotikhin AE; Shtil AA
Eur J Med Chem; 2021 Oct; 221():113521. PubMed ID: 34082225
[TBL] [Abstract][Full Text] [Related]
19. Anticancer potential of aminomethylidene-diazinanes I. Synthesis of arylaminomethylidene of diazinetriones and its cytotoxic effects tested in glioblastoma cells.
Pianovich NA; Dean M; Lassak A; Reiss K; Jursic BS
Bioorg Med Chem; 2017 Oct; 25(19):5068-5076. PubMed ID: 28864149
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]